![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.00 | 13.00 | 35.00 | 24.00 | 24.00 | 24.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.59 | 35.84M |
RNS Number:5977F Cambridge Antibody Tech Group PLC 03 July 2006 3 July 2006 Cambridge Antibody Technology Group plc ("CAT") CAT (LSE: CAT; NASDAQ: CATG) announces that with effect from 30 June 2006, Peter Chambre, John Aston, Diane Mellett, Paul Nicholson, Ake Stavling, Christopher Marshall, Peter Ringrose, John Stocker and John Brown have resigned as directors of the Company. With effect from 30 June 2006, the Company also announces that J W Hoskins has resigned as Company Secretary and that G H R Musker has been appointed Company Secretary. For further information please contact: Rowena Gardner, Director of Corporate Communications +44 (0) 1223 471 471 This information is provided by RNS The company news service from the London Stock Exchange END BOABLGDRXUGGGLX
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions